Glasgow PrognosticScore as a Predictor of BevacizumabEfficacy in the First-line Treatment with Metastatic Colorectal Cancer

Background: Inflammation might play an important role in promoting cancer growth partly by affecting tumor angiogenesis. We explored the role of Glasgow prognostic score (GPS) in metastatic colorectal cancer patients receiving first-linebevacizumab. Methods: All consecutive metastatic colorectal can...

Descripción completa

Detalles Bibliográficos
Autores principales: Huang, Yuanyuan, Li, Weiyu, Quan, Qi, Zhang, Bei, Yang, Qiong
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Ivyspring International Publisher 2019
Materias:
Research Paper
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6909943/
https://www.ncbi.nlm.nih.gov/pubmed/31839820
http://dx.doi.org/10.7150/jca.31182

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6909943/
https://www.ncbi.nlm.nih.gov/pubmed/31839820
http://dx.doi.org/10.7150/jca.31182

Ejemplares similares